Table 2.

Attributable risk of MACEs in different renal function in all the ACS patients

	Unadjusted			Adjusted
	OR	95%CI	P	ORa	95%CI	P	AR
eGFR ≥90 ml/min·1.73m2	ref			ref
60-89 ml/min·1.73m2	1.82	1.73-1.92	<0.001	1.27	1.19-1.35	<0.001	7.78%
45-59 ml/min·1.73m2	3.18	2.97-3.41	<0.001	1.65	1.52-1.80	<0.001	4.69%
30-44 ml/min·1.73m2	4.62	4.28-4.99	<0.001	2.04	1.85-2.26	<0.001	4.46%
<30 ml/min·1.73m2	6.06	5.55-6.61	<0.001	2.23	1.98-2.50	<0.001	3.36%

MACEs major adverse cardiovascular events; ACS acute coronary syndrome; eGFR estimated glomerular filtration rate

^aORs were adjusted for age, history of hypertension, diabetes mellitus, heart failure, atrial fibrillation, stroke, previous PCI or CABG, ACS type, heart failure at admission, cardiogenic shock at admission, cardiac arrest at admission, Killip class at admission, systolic pressure at admission, taking antiplatelet drugs before admission, taking β-blocker before admission and taking ACEI/ARB before admission, HB at admission, LDL-C at admission